StocksMedium•3 November 2026•
1 min read
Henry Schein Raises 2026 Guidance Following 26% Earnings Growth
Key Facts
1Henry Schein reported $3.5 billion in sales for the third quarter with total growth of 4.0%.
2GAAP earnings per share grew 26.2% compared to the prior year.
3The company raised its full-year 2026 financial guidance following strong third-quarter performance.
Henry Schein reported $3.5 billion in sales for the third quarter of 2026, representing total growth of 4.0%. According to a statement via Business Wire, GAAP earnings per share grew 26.2% compared to the prior year, leading the company to raise its financial guidance for the full fiscal year 2026.
HSIC closed at $86.62 on November 2, 2026, ahead of the results which highlighted internal growth of 3.1% in local currencies. The upward revision in guidance follows robust performance across healthcare solution segments, with the stock trading between a low of $85.13 and a high of $87.28 during its last session.